Roadmap

What we're building

Platform

Self-service admin

Domain-based team invites so sponsors can add users without contacting Teiko.

Shipped

Platform

Instant dashboard access at kickoff

Dashboard provisioned at work order signature, with verification reports and gating scheme pre-loaded.

Shipped

Platform

Assay variability overlay

CV bands shown on immune changes plots to distinguish noise from a true drug effect.

Shipped

Platform

Programmable panels tool

Configure and compare custom panel builds without cytometry expertise.

Shipped

Platform

Commentable gating

72-hour comment window for gate adjustments, with email notifications and rollback support.

Now
Q2 2026

Datasets

TokuKit performance across disease indications

Specimen stability and immune data comparisons across tumor indications. Downloadable for clinical trial planning.

Later
Q2 2026

Datasets

Expanded Validated Antibody Library for TokuKit

Expanding the library of validated antibodies compatible with TokuKit-preserved samples for multi-parameter immune profiling

Now
Q2 2026

Platform

TokuCompute

Import your own cytometry dataset for analysis. Currently in alpha with select sponsors.

Next
Q3 2026

Platform

Add your own metadata

Incorporate sponsor-provided metadata columns (e.g., responder status, dose group) directly in the dashboard.

Next
Q3 2026

Platform

Baseline normalization for population statistics

Compare treatment timepoints against each subject's own baseline, not just across cohorts.

Next
Q3 2026

Platform

Panel verification report in dashboard

Gating scheme and verification data accessible alongside study data from day one.

Next
Q3 2026

Lab Operations

Bone marrow panel validation

Validation of our TokuKit bone marrow specimen collection kit.

Next
Q4 2026

Datasets

TokuKit Temperature Stability

Assessing TokuKit sample stability across alternative storage temperatures and controlled transitions to -80°C storage conditions

Later
Q4 2026

Lab Operations

Absolute Cell Count Quantification from TokuKit-Preserved Samples

Evaluating methods to accurately quantify absolute immune cell counts from TokuKit-fixed whole blood samples

Later
Q4 2026

Platform

Auditable unsupervised clustering

Unsupervised clustering that meets CLIA-grade coefficients of variation. Results are human-interpretable and auditable, not a black box — so clinical trial teams can trust and defend them.

Later
TBD

Lab Operations

Flow Cytometry-Based Quantification of Antigen-Specific T Cells

Evaluating high-dimensional flow cytometry workflows for quantifying peptide-reactive T cells as an alternative to traditional ELISPOT assays

Later
TBD

Lab Operations

TokuKit performance on scRNA-sequencing / and other Next Generation Sequencing (NGS) assays

Assessing the compatibility of TokuKit-preserved samples with single-cell RNA sequencing and other next-generation sequencing workflows

Later
TBD

Platform

Commentable gating

72-hour comment window for gate adjustments, with email notifications and rollback support.

Now
Q2 2026

Datasets

Expanded Validated Antibody Library for TokuKit

Expanding the library of validated antibodies compatible with TokuKit-preserved samples for multi-parameter immune profiling

Now
Q2 2026

Platform

TokuCompute

Import your own cytometry dataset for analysis. Currently in alpha with select sponsors.

Next
Q3 2026

Platform

Add your own metadata

Incorporate sponsor-provided metadata columns (e.g., responder status, dose group) directly in the dashboard.

Next
Q3 2026

Platform

Baseline normalization for population statistics

Compare treatment timepoints against each subject's own baseline, not just across cohorts.

Next
Q3 2026

Platform

Panel verification report in dashboard

Gating scheme and verification data accessible alongside study data from day one.

Next
Q3 2026

Lab Operations

Bone marrow panel validation

Validation of our TokuKit bone marrow specimen collection kit.

Next
Q4 2026

Datasets

TokuKit performance across disease indications

Specimen stability and immune data comparisons across tumor indications. Downloadable for clinical trial planning.

Later
Q2 2026

Datasets

TokuKit Temperature Stability

Assessing TokuKit sample stability across alternative storage temperatures and controlled transitions to -80°C storage conditions

Later
Q4 2026

Lab Operations

Absolute Cell Count Quantification from TokuKit-Preserved Samples

Evaluating methods to accurately quantify absolute immune cell counts from TokuKit-fixed whole blood samples

Later
Q4 2026

Platform

Auditable unsupervised clustering

Unsupervised clustering that meets CLIA-grade coefficients of variation. Results are human-interpretable and auditable, not a black box — so clinical trial teams can trust and defend them.

Later
TBD

Lab Operations

Flow Cytometry-Based Quantification of Antigen-Specific T Cells

Evaluating high-dimensional flow cytometry workflows for quantifying peptide-reactive T cells as an alternative to traditional ELISPOT assays

Later
TBD

Lab Operations

TokuKit performance on scRNA-sequencing / and other Next Generation Sequencing (NGS) assays

Assessing the compatibility of TokuKit-preserved samples with single-cell RNA sequencing and other next-generation sequencing workflows

Later
TBD

Platform

Self-service admin

Domain-based team invites so sponsors can add users without contacting Teiko.

Shipped

Platform

Instant dashboard access at kickoff

Dashboard provisioned at work order signature, with verification reports and gating scheme pre-loaded.

Shipped

Platform

Assay variability overlay

CV bands shown on immune changes plots to distinguish noise from a true drug effect.

Shipped

Platform

Programmable panels tool

Configure and compare custom panel builds without cytometry expertise.

Shipped